ALK-rearranged pulmonary adenocarcinoma in Thai Patients: From diagnosis to treatment efficacy

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1477-7819
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
ALK-rearranged pulmonary adenocarcinoma in Thai Patients: From diagnosis to treatment efficacy ; volume:14 ; number:1 ; day:3 ; month:5 ; year:2016 ; pages:1-9 ; date:12.2016
World journal of surgical oncology ; 14, Heft 1 (3.5.2016), 1-9, 12.2016

Urheber
Incharoen, Pimpin
Beteiligte Personen und Organisationen
Reungwetwattana, Thanyanan
Saowapa, Sakditad
Kamprerasart, Kaettipong
Pangpunyakulchai, Duangjai
Arsa, Lalida
Jinawath, Artit
SpringerLink (Online service)

DOI
10.1186/s12957-016-0893-6
URN
urn:nbn:de:1111-201605056138
Rechteinformation
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 10:48 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Incharoen, Pimpin
  • Reungwetwattana, Thanyanan
  • Saowapa, Sakditad
  • Kamprerasart, Kaettipong
  • Pangpunyakulchai, Duangjai
  • Arsa, Lalida
  • Jinawath, Artit
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Pulmonary granulomatous inflammation after ceritinib treatment in advanced ALK-rearranged pulmonary adenocarcinoma

Pulmonary granulomatous inflammation after ceritinib treatment in advanced ALK-rearranged pulmonary adenocarcinoma

Major pathologic response to alectinib in ALK-rearranged adenocarcinoma of the lung

Major pathologic response to alectinib in ALK-rearranged adenocarcinoma of the lung

Clinical outcomes in ALK-rearranged lung adenocarcinomas according to ALK fusion variants

Clinical outcomes in ALK-rearranged lung adenocarcinomas according to ALK fusion variants

Intrathecal pemetrexed for leptomeningeal metastases in a patient with ALK-rearranged lung adenocarcinoma: a case report

Intrathecal pemetrexed for leptomeningeal metastases in a patient with ALK-rearranged lung adenocarcinoma: a case report

Targeting YAP to overcome acquired resistance to ALK inhibitors in ALK ‐rearranged lung cancer

Targeting YAP to overcome acquired resistance to ALK inhibitors in ALK ‐rearranged lung cancer

Gingival Metastasis of ALK Rearranged Non-Small Cell Lung Cancer

Gingival Metastasis of ALK Rearranged Non-Small Cell Lung Cancer

Successful Treatment of a Resistant Subclone in ALK-Rearranged NSCLC

Successful Treatment of a Resistant Subclone in ALK-Rearranged NSCLC

Early pneumothorax as a feature of response to crizotinib therapy in a patient with ALK rearranged lung adenocarcinoma

Early pneumothorax as a feature of response to crizotinib therapy in a patient with ALK rearranged lung adenocarcinoma

Complete morphologic response to gilteritinib in ALK-rearranged acute myeloid leukemia

Complete morphologic response to gilteritinib in ALK-rearranged acute myeloid leukemia

Vulnerability of drug‐resistant EML4‐ALK rearranged lung cancer to transcriptional inhibition

Vulnerability of drug‐resistant EML4‐ALK rearranged lung cancer to transcriptional inhibition

Different Therapeutic Strategies in 2 Young Patients with Advanced ALK-Rearranged Lung Adenocarcinoma: “The Light at the End of the Tunnel”

Different Therapeutic Strategies in 2 Young Patients with Advanced ALK-Rearranged Lung Adenocarcinoma: “The Light at the End of the Tunnel”

Transforming tumoroids derived from ALK-positive pulmonary adenocarcinoma to squamous cell carcinoma in vivo

Transforming tumoroids derived from ALK-positive pulmonary adenocarcinoma to squamous cell carcinoma in vivo

Verbundene Objekte